MIS MiLIF Versus Open
Study Details
Study Description
Brief Summary
This study is being undertaken to compare the clinical outcomes of patients that have unilateral posterolateral lumbar interbody fusion using a traditional open approach versus the MiLIF procedure based on the MiCOR Precision Bone Allograft, specialized Atavi instrumentation, and minimally invasive visualization capabilities.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
This is a prospective, multi-center, non-randomized cohort design clinical study to evaluate the clinical outcomes of patients that have a minimally invasive lumbar interbody fusion (MiLIF) through the Atavi system compared to traditional unilateral open lumbar interbody fusion through a midline incision. the study will involve up to approximately 12 investigational sites and enroll up to 126 patients.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Control Posterior unilateral interbody fusion using an open approach midline incision (TLIF) |
Device: The Atavi System
The primary device in the Atavi system is the Flex Posture retractor and accessories such as dilators and an Expander Instrument.
The Atavi System includes instruments used to access the spine by dilation of the overlying tissues, as well as a retracting device that is used to maintain the access. Once the retractor is in place, the visualization components of the system may be used.
Other Names:
|
Experimental MiLIF procedure with specialized Atavi instrumentation and minimally invasive visualization capabilities |
Device: The Atavi System
The primary device in the Atavi system is the Flex Posture retractor and accessories such as dilators and an Expander Instrument.
The Atavi System includes instruments used to access the spine by dilation of the overlying tissues, as well as a retracting device that is used to maintain the access. Once the retractor is in place, the visualization components of the system may be used.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Clinical Outcomes [MiLIF and Open groups at 3 months post-procedure as defined by the mean Oswestry score]
Secondary Outcome Measures
- Clinical Outcomes [The percent of patients that have a successful fusion at one year post-procedure as measured by radiographs]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient is between 18 and 75 years of age
-
Patient is scheduled for an elective spinal lumbar interbody single level fusion
-
Patient is a candidate for posterior unilateral lumbar fusion through a midline incision
-
Indication for surgery and dominant symptom of chronic low back and/or leg pain
-
Diagnosis of one or more of the following:
-
Primary symptomatic degenerative disc disease confirmed with appropriate imaging studies and/or positive lumbar discography
-
Spondylolisthesis Grade I/II
-
The affected motion segment reside in L2-S1 and are adjacent segments
-
Patient, or authorized representative, signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure.
Exclusion Criteria:
-
Patient has a known fracture in the lumbar spine
-
Patient has systemic infection or evidence of any surgical site infection (superficial or organ space)
-
Patient has compromised immune system or autoimmune disease (WBC<4000 or >20,000)
-
Patient has uncontrolled diabetes
-
Patient has a known malignancy
-
Prior lumbar fusion attempt; prior laminectomy and/or discectomy are allowed
-
Known medical or anatomical condition that would preclude a posterior lumbar fusion using metallic instrumentation (e.g., severe osteopenia)
-
Patient with a planned placement of an electric bone stimulator
-
Patient with a planned placement of indwelling epidural catheter for a long term pain management
-
Patient is pregnant or wishes to become pregnant during the length of the study participation
-
Patient is currently in litigation
-
Patient is not likely to comply with the follow-up evaluation schedule
-
Patient is participating in a clinical trial of another investigational drug or device.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | La Jolla Spine Institute | La Jolla | California | United States | 92037 |
2 | Sharp Rees-Stealy Medical Group | San Diego | California | United States | 92123 |
3 | Advanced Orthopedic Center | Port Charlotte | Florida | United States | 33948 |
4 | Southeastern Spine Center | Sarasota | Florida | United States | 34232 |
5 | Kennedy-White Orthopedic | Sarasota | Florida | United States | 34233 |
6 | Oregon Brain & Spinal Institute | Portland | Oregon | United States | 97225 |
7 | Williamette Neurosurgery | Salem | Oregon | United States | 97302 |
8 | William Beaumont Army Medical Center | El Paso | Texas | United States | 97720-5001 |
9 | Naval Medical Center | Portsmouth | Virginia | United States | 23708 |
Sponsors and Collaborators
- Zimmer Biomet
Investigators
- Study Director: Joe Murar, M.D., Zimmer Spine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ATV-03-002
- 2007-003